The hepatitis C virus internal ribosome entry site facilitates efficient protein synthesis in blood vessel endothelium during tumour angiogenesis.
The development of gene delivery systems for therapeutic use involves vectors (often retrovirus or adenovirus) which typically encode one target protein, but the use of internal ribosome entry sites (IRES) can confer the ability to express more than one protein from bi- or polycistronic mRNAs. IRES...
Κύριοι συγγραφείς: | Chung, G, Yamada, Y, Pannell, R, Forster, A, Rabbitts, T |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2003
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
ανά: Yamada, Y, κ.ά.
Έκδοση: (2002) -
The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
ανά: Yamada, Y, κ.ά.
Έκδοση: (2000) -
RNA-Protein Interactome at the Hepatitis E Virus Internal Ribosome Entry Site
ανά: Shiv Kumar, κ.ά.
Έκδοση: (2023-08-01) -
IRESpy: an XGBoost model for prediction of internal ribosome entry sites
ανά: Junhui Wang, κ.ά.
Έκδοση: (2019-07-01) -
Polypyrimidine-Tract-Binding Protein Isoforms Differentially Regulate the Hepatitis C Virus Internal Ribosome Entry Site
ανά: Jenniffer Angulo, κ.ά.
Έκδοση: (2022-12-01)